LENZ Therapeutics, Inc. (LENZ)

NASDAQ: LENZ · Real-Time Price · USD

5.89

+0.10 (1.73%)

At close: Jul 2, 2026, 4:00 PM EDT

5.90

+0.01 (0.17%)

After-hours: Jul 2, 2026, 6:55 PM EDT

LENZ Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.77	25.18	20.16	35.14	47.73	376.98
Short-Term Investments	233.61	267.17	188.87	30.65	220.5	-
Cash & Short-Term Investments	258.39	292.35	209.03	65.79	268.23	376.98
Cash Growth	33.20%	39.86%	217.70%	-75.47%	-28.85%	1805.65%
Accounts Receivable	0.34	0.33	-	-	-	-
Inventory	3.5	2.94	-	-	-	-
Other Current Assets	6.14	5.8	2.89	1.45	7.14	4.76
Total Current Assets	268.37	301.41	211.92	67.24	275.37	381.74
Net Property, Plant & Equipment	1.72	1.92	1.99	0.37	28.21	18.08
Long-Term Investments	-	-	-	-	15.32	-
Other Long-Term Assets	2.45	2.54	1.4	2.76	3.01	2.17
Total Assets	272.54	305.88	215.3	70.38	321.9	401.99
Accounts Payable	10.93	4.17	4.26	5.71	2.61	2.45
Accrued Expenses	14.88	17.02	6.15	12.8	6.39	4.21
Current Portion of Leases	-	-	-	-	4.05	5.48
Total Current Liabilities	25.81	21.19	10.41	18.51	13.04	12.14
Long-Term Leases	0.24	0.35	0.81	0.19	1.75	5.79
Other Long-Term Liabilities	-	-	-	0.99	10.82	-
Total Long-Term Liabilities	0.24	0.35	0.81	1.18	12.57	5.79
Total Liabilities	26.04	21.54	11.22	19.7	25.61	17.94
Common Stock	0	0	0	5.91	0	0
Additional Paid-in Capital	515.57	511.24	348.9	2.52	539.74	525.4
Accumulated Other Comprehensive Income	-0.45	0.24	0.2	0.01	-1.05	-
Retained Earnings	-268.63	-227.14	-145.01	-95.25	-242.4	-141.35
Total Common Shareholders' Equity	246.49	284.34	204.08	-86.81	296.29	384.05
Minority Interest	-	-	-	137.49	-	-
Shareholders' Equity	246.49	284.34	204.08	50.68	296.29	384.05
Total Liabilities & Equity	272.54	305.88	215.3	70.38	321.9	401.99
Total Debt	0.24	0.35	0.81	0.19	5.79	11.28
Net Cash (Debt)	258.15	292	208.22	65.6	262.44	365.7
Net Cash Growth	-11.59%	40.24%	217.39%	-75.00%	-28.24%	1748.65%
Net Cash Per Share	8.67	10.13	9.78	15.88	63.52	88.52
Book Value	246.49	284.34	204.08	-86.81	296.29	384.05
Book Value Per Share	8.28	9.87	9.59	-21.01	71.72	92.96
Tangible Book Value	246.49	284.34	204.08	-86.81	296.29	384.05
Tangible Book Value Per Share	8.28	9.87	9.59	-21.01	71.72	92.96

SEC Filings: 10-K · 10-Q